Gulf Pharmaceutical Industries P.S.C.'s latest marketcap:
As of 04/30/2026, Gulf Pharmaceutical Industries P.S.C.'s market capitalization has reached $324.02 M. According to our data, Gulf Pharmaceutical Industries P.S.C. is the 18367th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 324.02 M |
| Revenue (ttm) | 292.87 M |
| Net Income (ttm) | 46.89 M |
| Shares Out | 1.16 B |
| EPS (ttm) | 0.04 |
| Forward PE | 51.50 |
| Ex-Dividend Date | 04/25/2017 |
| Earnings Date | 05/11/2026 |
Gulf Pharmaceutical Industries P.S.C.'s yearly market capitalization.
| Date | Market Cap(AED) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/01/2026 | AED1.26 B | $342.83 M | -6.84% | n/a |
| 12/31/2025 | AED1.35 B | $368.08 M | -10% | 15083 |
| 12/31/2024 | AED1.5 B | $408.11 M | 69.05% | 14344 |
| 12/29/2023 | AED888.37 M | $241.41 M | -33.71% | 17706 |
| 12/30/2022 | AED1.34 B | $364.23 M | -36.96% | 14311 |
| 12/30/2021 | AED2.13 B | $577.62 M | 38.35% | 12447 |
| 12/31/2020 | AED1.54 B | $0 | 35.75% | 12612 |
| 12/31/2019 | AED1.13 B | $307.59 M | -49.9% | 12619 |
| 12/31/2018 | AED2.26 B | $613.95 M | -16.66% | 8097 |
| 12/28/2017 | AED2.71 B | $736.73 M | 14.4% | 8551 |
Company Profile
About Gulf Pharmaceutical Industries P.S.C.
Gulf Pharmaceutical Industries P.S.C. (Julphar) is a leading pharmaceutical company that manufactures and distributes a wide range of medicines, drugs, and healthcare products. Established in 1980 and headquartered in Ras al-Khaimah, UAE, the company operates across the GCC and internationally.
Business Segments
- Manufacturing: Produces pharmaceutical and medical compounds.
- Planet: Focuses on retail and distribution.
- Investments: Engages in commercial and healthcare ventures.
- Others: Includes logistics, facilities management, and medical equipment trading.
Product Portfolio
The company offers a diverse range of medicines, including:
- Generic drugs for pain, inflammation, and antiviral treatments
- Cardiovascular, respiratory, and CNS medications
- Vitamins, supplements, and dermatology products
- Diabetes care solutions, including insulin and glucose monitoring systems
- Specialized treatments for gynecology, urology, and gastrointestinal health
Additional Services
Julphar also provides:
- Wholesale and retail distribution of pharmaceuticals and cosmetics
- Healthcare facility management and hospital operations
- Medical equipment trading
Frequently Asked Questions
-
What is Gulf Pharmaceutical Industries P.S.C.'s (ADX-JULPHAR) current market cap?As of 04/30/2026, Gulf Pharmaceutical Industries P.S.C. (including the parent company, if applicable) has an estimated market capitalization of $324.02 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Gulf Pharmaceutical Industries P.S.C. (ADX-JULPHAR) rank globally by market cap?Gulf Pharmaceutical Industries P.S.C. global market capitalization ranking is approximately 18367 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.